CC(C)(O)C#Cc1ccc(C(=O)N2CCCC(CNS(=O)(=O)c3cccs3)C2)o1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?